Hospital News
Return to Bladder Cancer Overview
More on Bladder Cancer
- The Endangered Future of the Physician-Scientist
- Update on Lymphoma Drug Trial:Potential Breakthrough for T-Cell Lymphoma Patients With Drug That Mimics a Vitamin
- NewYork-Presbyterian Hospital/Columbia University Medical Center Fertility Experts Present the Latest Research at Reproductive Medicine Meeting
- Nutrition Advice for Cancer Patients and Survivors Available in New DVD
- NewYork-Presbyterian Hospital/Columbia University Medical Center Physician-Scientists Present at American Society of Clinical Oncology 44th Annual Meeting
- NewYork-Presbyterian/Weill Cornell Physician-Scientists Present Latest Cancer Findings at American Society of Clinical Oncology (ASCO) Meeting
- Study Looks at New Bladder Cancer Therapy for Patients Unresponsive to Standard Treatment
- NewYork-Presbyterian/Weill Cornell Creates World-Class Cancer Center
- Message to the Elderly: It's Never Too Late to Prevent Illness!
- Two Novel Biologics Studied for Multiple Myeloma
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
Health Library
Return to Bladder Cancer Overview
More on Bladder Cancer
- Angiogenesis Inhibitors
- Bladder Cancer
- Brachytherapy
- Cancer: Diagnostic Procedures
- Cancer: General Information
- Cancer: Grading and Staging
- Cancer: Hormone Therapy
- Cancer: Overview
- Cancer: Surgical Treatment
- Cancer: Treatment Overview
- Cancer Rehabilitation
- Chemotherapy
- Clinical Trials / Investigational Studies
- Radiation Therapy
Clinical Services
Return to Bladder Cancer Overview
More on Bladder Cancer
- Blood Cancer
- Brain Cancer
- Cancer (Oncology)
- Center for Holistic Urology
- Center for Lymphoma and Myeloma
- Colon Cancer
- Early Lung Cancer Action Program
- Edward S. Harkness Eye Institute
- Esophageal Cancer
- Eye Cancer
- Food and Nutrition
- Gastrointestinal Cancer
- Gynecological Cancer
- Head and Neck Cancer
- Kidney Cancer
- Leukemia and Myeloproliferative Disease Center
- Leukemia Fighters Fund
- Liver Cancer
- Lung Cancer
- Mesothelioma
- Pancreatic and Biliary Cancer
- Pediatric Cancer
- Prostate Cancer
- Rectal Cancer
- Robert M. Ellsworth Ophthalmic Oncology Center
- Soft Tissue and Bone Cancer
- Spirit of Care Program
- Stomach Cancer
- Testicular Cancer
- Urologic Cancer
Cancer (Oncology)
Bladder Cancer
Back to the nypcancer.org Home Page
Therapeutic Excellence
Neobladder
New York-Presbyterian Hospital physicians performed the first continent urinary diversion operations in the northeastern United States and the first construction of a replacement neobladder (or new bladder) in New York State. The operations have revolutionized the care of patients who may require radial cystectomy, or bladder removal, by avoiding the need for an external appliance or bag following surgery. The neobladder is made from small intestine and attached to the urethra to help patients urinate in a more normal way. According to a recent study, complication rates following the surgery at NewYork-Presbyterian Hospital/Columbia University Medical Center were among the lowest ever reported.
Prevention
NewYork-Presbyterian Cancer Centers are leaders in preventive medicine for bladder cancer and are currently conducting extensive studies into the use of natural substances to inhibit the Cox-2 gene for prevention and treatment. In general, recommendations include abstaining from smoking, a significant risk factor for developing this disease, and using appropriate precautions to limit occupational exposure to certain dyes, rubber and leather, which have been shown to increase the risk of bladder cancer.
Hospital News
- The Endangered Future of the Physician-Scientist
- Update on Lymphoma Drug Trial:Potential Breakthrough for T-Cell Lymphoma Patients With Drug That Mimics a Vitamin
- NewYork-Presbyterian Hospital/Columbia University Medical Center Fertility Experts Present the Latest Research at Reproductive Medicine Meeting More
